Journalartikel

Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension


AutorenlisteRichter, Manuel J.; Harutyunova, Satenik; Bollmann, Tom; Classen, Simon; Fuge, Jan; Gall, Henning; Gerhardt, Felix; Ghofrani, Hossein A.; Gunkel, Hartmut; Gruenig, Ekkehard; Halank, Michael; Heine, Alexander; Klose, Hans; Lange, Tobias J.; Neurohr, Claus; Nickolaus, Kai; Opitz, Christian F.; Rosenkranz, Stephan; Seyfarth, Hans-Juergen; Tello, Khodr; Ewert, Ralf; Olsson, Karen M.

Jahr der Veröffentlichung2020

ZeitschriftPulmonary Circulation

Bandnummer10

Heftnummer1

ISSN2045-8932

eISSN2045-8940

Open Access StatusGold

DOI Linkhttps://doi.org/10.1177/2045894020910136

VerlagWiley


Abstract
Implantable infusion pumps might improve the convenience and safety of intravenous treprostinil for pulmonary arterial hypertension. The LENUS Pro (R) pump (approved in Europe) has a fixed flow rate. Based on 126 pumps and 2853 refills, we retrospectively analyzed the actual flow rate from 09/2010 to 09/2018. A relevant flow rate variance is evident after three years; therefore, flow rate monitoring and dose adjustment are mandatory.



Zitierstile

Harvard-ZitierstilRichter, M., Harutyunova, S., Bollmann, T., Classen, S., Fuge, J., Gall, H., et al. (2020) Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension, Pulmonary Circulation, 10(1), Article 2045894020910136. https://doi.org/10.1177/2045894020910136

APA-ZitierstilRichter, M., Harutyunova, S., Bollmann, T., Classen, S., Fuge, J., Gall, H., Gerhardt, F., Ghofrani, H., Gunkel, H., Gruenig, E., Halank, M., Heine, A., Klose, H., Lange, T., Neurohr, C., Nickolaus, K., Opitz, C., Rosenkranz, S., Seyfarth, H., ...Olsson, K. (2020). Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension. Pulmonary Circulation. 10(1), Article 2045894020910136. https://doi.org/10.1177/2045894020910136



Schlagwörter


implantable infusion pumpprostanoidPulmonary hypertension


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 11:10